Compumedics signs China sleep diagnostics deal:
This article was originally published in Clinica
Melbourne, Australia-based Compumedics is to expand its presence in China through a new agreement with Hong Kong-based Celki Medical Company, which will exclusively distribute Compumedics' sleep diagnostics equipment in the south of the country. Compumedics believes this contract and a separate deal for north China with Best-Med (China) Development will be worth Aus$1.4m (US$1.1m) in the first year.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.